欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/V/0364/005
药品名称Alpramil 12.5 mg/125 mg tablets for dogs weighing at least 5 kg
活性成分
    • milbemycin A<3>-oxim 12.5 mg
    • praziquantel 125.0 mg
剂型Tablet
上市许可持有人Alfasan Nederland BV Kuipersweg 9 3449 JA Woerden The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Cyprus (CY)
    • Spain (ES)
    • Czechia (CZ)
    • Portugal (PT)
    • Romania (RO)
    • Italy (IT)
    • Slovakia (SK)
    • Greece (GR)
    • Slovenia (SI)
    • Norway (NO)
    • Croatia (HR)
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
    • Poland (PL)
    • Germany (DE)
    • Latvia (LV)
    • Belgium (BE)
      Alpramil 12,5 mg/125 mg
    • Lithuania (LT)
    • Luxembourg (LU)
    • Estonia (EE)
    • Iceland (IS)
    • Hungary (HU)
    • Ireland (IE)
    • Bulgaria (BG)
    • France (FR)
      MILPRAMAX 12,5/125 MG COMPRIMES POUR CHIENS
许可日期2022/02/09
最近更新日期2022/06/20
药物ATC编码
    • QP54AB51 milbemycin oxime, combinations
申请类型
  • TypeLevel1:non-food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase